Trial · NCT00106691
Results by group32
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 32
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Efficacy of Toremifene in the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia (PIN) | Placebo | 54.9 | 95% Confidence Interval 36.0 | % of participants cancer-free 36 months | |
| Efficacy of Toremifene in the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia (PIN) | Toremifene 20mg | 59.5 | 95% Confidence Interval 36.0 | % of participants cancer-free 36 months | |
| The Effect of Toremifene on Lipid Levels | Placebo | Cholesterol | -3.678 | Standard Deviation 18.2317 | % of change |
| The Effect of Toremifene on Lipid Levels | Toremifene 20mg | Cholesterol | -6.675 | Standard Deviation 116.9705 | % of change |
| The Effect of Toremifene on Lipid Levels | Placebo | LDL | -7.447 | Standard Deviation 64.8765 | % of change |
| The Effect of Toremifene on Lipid Levels | Toremifene 20mg | LDL | -7.824 | Standard Deviation 28.8209 | % of change |
| The Effect of Toremifene on Lipid Levels | Placebo | HDL | 3.69 | Standard Deviation 19.133 | % of change |
| The Effect of Toremifene on Lipid Levels | Toremifene 20mg | HDL | 0.29 | Standard Deviation 16.650 | % of change |
| The Effect of Toremifene on Lipid Levels | Placebo | Triglycerides | 16.298 | Standard Deviation 58.003 | % of change |
| The Effect of Toremifene on Lipid Levels | Toremifene 20mg | Triglycerides | 0.319 | Standard Deviation 47.9793 | % of change |
| The Effect of Toremifene on Hormone Levels | Placebo | DHT | 17.736 | Standard Deviation 48.3284 | % of change |
| The Effect of Toremifene on Hormone Levels | Toremifene 20mg | DHT | 46.409 | Standard Deviation 60.2061 | % of change |
| The Effect of Toremifene on Hormone Levels | Placebo | Estradiol | 11.9 | Standard Deviation 67.86 | % of change |
| The Effect of Toremifene on Hormone Levels | Toremifene 20mg | Estradiol | 53.2 | Standard Deviation 151.5 | % of change |
| The Effect of Toremifene on Hormone Levels | Placebo | Testosterone total | 2.246 | Standard Deviation 102.9086 | % of change |
| The Effect of Toremifene on Hormone Levels | Toremifene 20mg | Testosterone total | 31.136 | Standard Deviation 63.5961 | % of change |
| The Effect of Toremifene on Hormone Levels | Placebo | Testosterone free | 17.71 | Standard Deviation 438.652 | % of change |
| The Effect of Toremifene on Hormone Levels | Toremifene 20mg | Testosterone free | 7.92 | Standard Deviation 65.114 | % of change |
| The Effect of Toremifene on Total PSA (Prostate Specific Antigen) Levels | Placebo | 0.82 | Standard Deviation 7.360 | mcg/L | |
| The Effect of Toremifene on Total PSA (Prostate Specific Antigen) Levels | Toremifene 20mg | 1.07 | Standard Deviation 3.632 | mcg/L |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00106691/results